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Classification and implications for long-term outcome
B.K. Lal, E.A. Kaperonis, S. Cuadra, I. Kapadia and R.W. Hobson
Objectives. Factors predicting in-stent restenosis (ISR) and future need for
target lesion revascularization (TLR) after carotid artery stenting (CAS) re-
main undetermined. We hypothesized that the patterns of restenotic lesions
may provide prognostic information. In this study, we developed an ultra-
sound classification scheme for ISR based on lesion length and distribution
and assessed factors that may predict the need for TLR.
Methods. Patients were followed up after CAS with B-mode ultrasound im-
aging, and ISR lesions (40% stenosis) were classified into type I (focal 10
mm end-stent lesions), II (focal 10 mm, intrastent), III (diffuse >10 mm, in-
trastent), IV (diffuse >10 mm proliferative, extending outside the stent), and
V (total occlusion). The frequency of lesion types was assessed. Accuracy of
the ultrasound classification was confirmed with angiography. We recorded
patient (age, gender, comorbidities), lesion (severity, etiology, symptomatic
status) and procedural features (type, number, length of stents), and the
need for TLR.
Results. Eighty-five ISR lesions developed after 255 CAS procedures. Their
percentage distribution was type I, 40; type II, 25.9; type III, 12.9; for type
IV, 20; and type V, 1.2. Accuracy of the ultrasound classification was con-
firmed by angiography (r2 ¼ 0.82). Inter-rater agreement for the assignment
of lesion type based on ultrasound was 0.88 (very good). TLR was performed
in 13 that were 80% diameter reducing. On univariate analysis, the need for
TLR was highest in type IV lesions (0%, 0%, 27.3%, and 58.8% [types I to IV,
respectively]; P ¼ .001). History of ISR (2.9%, 0%, 0%, and 41.2% [types I to
IV]; P ¼ .003) and diabetes mellitus (20.6%, 22.7%, 45.5%, and 52.9% [types
I to IV]; P ¼ .02) occurred more frequently with type IV ISR lesions. On mul-
tivariate analysis of all patient, lesion, and procedural characteristics, only the
type of ISR (odds ratio, 5.1) and a history of diabetes (odds ratio, 9.7) were
independent predictors of TLR.
Conclusions. The proposed classification accurately grades the magnitude of
intimal hyperplasia after CAS and provides important prognostic informa-
tion. Diffuse proliferative (type IV) ISR lesions and diabetes are important de-
terminants of long-term outcome after CAS. This classification will facilitate
a standardized description of recurrence after CAS and enable early identifi-
cation of high-risk patients for additional monitoring, treatment, and
investigation.
Increased aortic arch calcification in patients older than 75 years:
Implications for carotid artery stenting in elderly patients
H.A. Bazan, S. Pradhan, H. Mojibian, T. Kyriakides and A. Dardik
Objective. Recent studies reveal a consistently higher periprocedural risk of
stroke during carotid artery stenting in octogenarians compared with youn-
ger patients. The mechanisms accounting for this increased risk of emboliza-
tion and stroke in elderly patients are poorly understood. We analyzed the
calcium content and aortic arch type in a consecutive series of patients to de-
termine whether aortic arch calcium content is related to either age or arch
type classification.
Methods. Aortic arch calcium content and arch classification were examined
in consecutive patients undergoing thoracic computed tomography scans.
The calcium content of the aortic arch, measured from the aortic root to the
descending thoracic aorta at the level of the carina, was determined by using
a coronary calcium score grade. The aortic arch classification was determined
by using two-dimensional and multiplanar image reconstructions. Linear re-
gression and analysis of variance were used to determine the effect of age,
arch classification, and patient comorbidity on aortic arch calcium content.
Results. The computed tomography scans of 94 patients were analyzed.
There was a positive correlation between age and aortic arch calcium content;
the mean calcium score (Agatston units) for patients increased by decade
(age < 50 years, 12.6  12.3, n ¼ 18; age 50e59 years, 14.6  8.2, n ¼ 21; age
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80 years, 3889  778, n ¼ 11; P < .001). There was significantly more arch
calcium in patients 75 years or older compared with patients younger than
75 years (2458  447 vs 145  49; P < .001). There was no effect of patient co-
morbidity on aortic arch calcium content. Patients with type II aortic arches
were older and had a higher calcium content compared with patients with
type I aortic arches (2028  546 vs 712  191; P ¼ .01). Power analysis showed
more than 99% power to detect differences between patients younger than 75
years and 75 years or older.
Conclusions. Patients 75 years of age or older have significantly more aortic
arch calcification compared with younger patients. Increased arch calcium
content and type II aortic arches may be markers of increased potential for
embolization during endovascular manipulation that transverses the aortic
arch. Preprocedural determination of aortic arch calcification and morphol-
ogy may help to further stratify periprocedural carotid artery stenting risk
in elderly patients.
Determinants of hypotension and bradycardia after carotid angioplasty
and stenting
P.H. Lin, W. Zhou, P. Kougias, H.F. El Sayed, N.R. Barshes and T.T. Huynh
Background. Acute procedurally induced hemodynamic depression can oc-
cur after carotid angioplasty and stenting (CAS). This study was performed
to determine the frequency and risk factors for hypotension and bradycardia
after the CAS procedure.
Methods. The study reviewed clinical variables and angiographic data of all
patients undergoing elective CAS with neuroprotection during a recent 5-
year period. Intravenous atropine was given selectively in cases of bradycar-
dia (heart rate <60 beats/min or a decrease of >20 beats/min). We further
defined hemodynamic depression as bradycardia or severe hypotension (sys-
tolic blood pressure fall >30 mm Hg). Frequency and potential risk factors for
hemodynamic depression were analyzed by logistic regression.
Results. During the study period, 416 patients (99% male; mean age, 74  11
years) underwent the CAS procedure. The median degree of stenosis was
93% (range, 60% to 99%). The frequencies of post-CAS hemodynamic depres-
sion include hypotension in 58 (14%), bradycardia in 112 (27%), or both in 21
(5%). All patients with bradycardia received intraprocedural atropine, and all
heart rates returned to the baseline level. Persistent hypotension occurred in
45 patients (11%). Increased age was predictive for CAS-induced bradycardia
or hypotension. Adjusted risk factors associated with hemodynamic depres-
sion include age >78 years (odds ratio [OR], 5.25; 95% confidence interval
[CI], 2.32 to 15.25; P ¼ .01) and ejection fraction of <25% (OR, 3.25; 95% CI,
0.58 to 6.58; P ¼ .02). CEA-related restenosis was associated with a reduced
risk of hemodynamic depression (OR, 0.21; 95% CI, 0.12 to 0.69, P ¼ .001).
Persistent hypotension after CAS was associated with an increased risk of
an adverse clinical event (44%, P ¼ .001).
Conclusions. Hemodynamic depression, including hypotension and
bradycardia, is frequent after CAS. However, CAS-induced hemodynamic
depression is rare in patients with postendarterectomy stenosis. Patients with
compromised ejection fraction and increased age are at a higher risk of present-
ing with CAS-induced hemodynamic instability, and persistent hypotension
after CAS is associated with an increased postprocedural complication rate.
Cost-effectiveness of conventional and endovascular repair of
abdominal aortic aneurysms: Results of a randomized trial
M. Prinssen, E. Buskens, S.E. de Jong, J. Buth, A.J. Mackaay, M.R. Sambeek
and J.D. Blankensteijn for the DREAM trial participants
Background. Two randomized trials have shown similar mid-term outcomes
for survival and quality of life after endovascular and conventional open
repair of abdominal aortic aneurysms (AAA). With reduced hospital and
intensive care stay, endovascular repair has been hypothesized to be more
efficient than open repair. The Dutch Randomized Endovascular AneurysmSeptember 2007  619/621
of European Society for Vascular Surgery.
620 AbstractsManagement (DREAM) trial was undertaken to assess the balance of costs
and effects of endovascular vs open aneurysm repair.
Methods. We conducted a multicenter, randomized trial comparing endovas-
cular repair with open repair in 351 patients with an AAA and studied costs,
cost-effectiveness, and clinical outcome 1 year after surgery. In addition to
clinical outcome, costs and quality of life were recorded up to 1 year in 170
patients in the endovascular repair group and in 170 in the open repair group.
Incremental cost-effectiveness ratios were estimated for cost per life-year,
event-free life-year, and quality adjusted life-year (QALY) gained. Uncer-
tainty regarding these outcomes was assessed using bootstrapping.
Results. Patients in the endovascular repair group experienced 0.72 QALY
vs 0.73 in the open repair group (absolute difference, 0.01; 95% confidence
interval [CI], 0.038 to 0.058). Endovascular repair was associated with addi-
tional V4293 direct costs (V18,179 vs V13.886; 95% CI, V2,770 to V5,830).
Most of the bootstrap estimates indicated that endovascular repair resulted
in slightly longer overall and event-free survival associated with respective
incremental cost-effectiveness ratios of V76,100 and V171,500 per year
gained. Open repair appeared the dominant strategy in costs per QALY.
Conclusion. Presently, routine use of endovascular repair in patients also el-
igible for open repair does not result in a QALY gain at 1 year postoperatively,
provides only a marginal overall survival benefit, and is associated with
a substantial, if not prohibitive, increase in costs.
Dynamic geometry and wall thickness of the aortic neck of abdominal
aortic aneurysms with intravascular ultrasonography
F.R. Arko, E.H. Murphy, C.M. Davis III, E.D. Johnson, S.T. Smith and C.K.
Zarins
Background. It is commonly assumed that the aortic wall deforms uniformly
and has uniform wall thickness about the circumference. The purpose of this
study was to evaluate the aortic wall motion and thickness in the infrarenal
aortic neck of patients with abdominal aortic aneurysms who were undergo-
ing endovascular repair (EVAR) and to compare the dynamic measurements
of intravascular ultrasonography with the static measurements of computed
tomographic angiography (CTA).
Methods. A total of 25 patients were evaluated before surgery with CTA and
three-dimensional reconstructions on a Vitrea workstation, followed by intra-
operative assessment of the proximal aortic neck with intravascular ultraso-
nography (IVUS) before EVAR. Infrarenal aortic neck dimensions on CTA
were obtained at 1-mm intervals, but for the purposes of this study all dimen-
sions on CTAwere obtained 1 cm below the lowest renal artery. IVUS analysis
of the proximal aortic neck was obtained with a 10-second recorded data loop
of aortic wall motion. A Digital Imaging and Communications in Medicine
viewer was used to view the recorded loop of aortic movement, and each im-
age was captured and then evaluated with a SCION PCI Frame Grabber to
determine aortic dimensions and wall thickness. IVUS diameters (250 mea-
surements of each aorta) were recorded through a full continuous cardiac cy-
cle from the epicenter of the lumen (maintaining the left renal vein in its
normal anatomic configuration) in an anteroposterior (AP) direction in the
area of greatest wall movement and 90  perpendicular to this direction (lat-
eral movement).
Results. There was significant variation in infrarenal aortic wall movement
about the circumference, with 1.7  0.6 mm (range, 0.6e2.7 mm) displace-
ment in the AP direction and 0.9  0.5 mm (range, 0.3e1.5 mm) displacement
in the lateral direction (P < .001). Aortic wall thickness was greater in the re-
gion of increased AP wall motion than in the area of lesser lateral wall motion
(2.3  0.6 mm vs 1.2  0.3 mm; P < .001). There was no difference between the
IVUS and CTA aortic neck measurements (25.5 vs 25.6 mm; not significant)
during the midpoint of the cardiac cycle of IVUS. However, at peak systole,
IVUS recorded a greater diameter than CTA (26.4 vs 25.6 mm; P < .001), and
at end-diastole, IVUS recorded a smaller diameter than CTA (24.7 vs 25.6
mm; P ¼ .01).
Conclusions. The infrarenal neck of aortic aneurysms deforms anisotropi-
cally during the cardiac cycle. The greatest displacement is in the AP
direction and corresponds with a significantly greater wall thickness in this
area. The magnitude of cyclic change in aortic diameter can be as high as
11%. Further evaluation of proximal aortic neck wall motion after EVAR
is warranted to determine the interaction of various stent designs and the
aortic wall.Eur J Vasc Endovasc Surg Vol 34, November 2007Endovascular management of acute blunt traumatic thoracic aortic
injury: A single center experience
C.L. Bent, M.B. Matson, M. Sobeh, I. Renfrew, R. Uppal, M. Walsh, K. Brohi
and C. Kyriakides
Background. Traumatic injury of the thoracic aorta is a life-threatening com-
plication in patients who sustain deceleration or crush injuries. The magni-
tude of force necessary to cause blunt thoracic aortic injury results in
a high proportion of concomitant injuries, posing a significant challenge for
prioritizing management. Open surgical mortality is increased in the pres-
ence of coexisting head, lung, and abdominal injuries. Spinal cord ischemia
may occur following aortic cross-clamping and operative hypotension. Endo-
vascular stent-graft placement offers a safe, effective, and timely treatment
option. The aim of this study was to assess our single center experience of en-
dovascular repair following acute blunt traumatic aortic injury.
Methods. Data from thirteen consecutive patients (mean age, 43.2 years;
range, 16 to 84 years) with acute blunt traumatic aortic injury treated by en-
dovascular stent-graft insertion between October 2001 and March 2007 was
prospectively collected. Demographics, injury characteristics, technique,
and complications were recorded. Follow-up data consisted of computed to-
mographic angiography and plain chest radiography at regular intervals.
Mean and median follow-up after stent-graft implantation were 28.9 and 29
months, respectively.
Results. All patients underwent endovascular repair within a median of 9
hours from hospital presentation. Two patients underwent carotico-carotid
bypass immediately prior to endovascular stenting during a single anesthetic.
Stent-graft implantation was technically successful in all patients. No patient
required conversion to open surgical repair of the acute blunt traumatic aortic
injury. Procedure-related paraplegia was zero. Complications included prox-
imal migration of initial stent-graft in one patient and iliac artery avulsion in
another patient with consequent ilio-femoral bypass. The median hospital
stay was 17 days. There were no in-hospital deaths.
Conclusion. Endovascular repair is evolving as the procedure of choice for
acute blunt traumatic aortic injury. Treatment of lesions that extend into the
aortic arch is feasible with extra-anatomical bypass. In our study, endovascu-
lar repair of blunt traumatic aortic injury is a safe procedure with low
morbidity and a mortality rate of zero.
Impact of diabetes mellitus on outcomes of superficial femoral artery
endoluminal interventions
A.M. Bakken, E. Palchik, J.P. Hart, J.M. Rhodes, W.E. Saad and M.G. Davies
Background. Although aggressive endoluminal therapy for superficial femo-
ral artery (SFA) occlusive disease is commonplace, the implications of diabe-
tes mellitus (DM) on long-term outcomes in this population are unclear. We
examined the consequences of endovascular treatment of the SFA in patients
with and without DM.
Methods. A database of patients undergoing endovascular treatment of
the SFA between 1986 and 2005 was maintained. Three groups were
defined: nondiabetic patients, those with non-insulin-dependent DM
(NIDDM), and those with insulin-dependent DM (IDDM). Intention-to-treat
analysis was performed. Results were standardized to TransAtlantic Inter-
Society Consensus (TASC) and Society for Vascular Surgery criteria. Time-
dependent outcomes were assessed with Kaplan-Meier survival analyses.
Factor analyses were performed using a Cox proportional hazard model
for time-dependent variables. Data are presented as mean  SD where
appropriate.
Results. Endovascular treatment (ie, balloon angioplasty  adjuvant stenting
in 38%) was initiated in 525 limbs in 437 patients (68% male; average age, 66
 14 years) for claudication failing conservative therapy or chronic critical
limb ischemia (CLI). Of these, 50% were nondiabetic, 26% had NIDDM, and
24% had IDDM. Analyses were separated by those presenting with claudica-
tion (61%) and those presenting with CLI (39%). Among patients presenting
with claudication, those with IDDM had significantly lower assisted primary
patency (P < .01) and a higher incidence of restenosis (P ¼ .04). Patencies at 3
years for nondiabetic, NIDDM, and IDDM were 62%, 72%, and 54% (pri-
mary), and 81%, 86%, and 65% (assisted primary), respectively. Patency
and restenosis rates were associated with lesion calcification, TASC D lesion
categorization, and acute periprocedural occlusion. Among patients present-
ing with CLI, patency and restenosis rates were equivalent across all groups;
621Abstractshowever, limb salvage was significantly worse for both groups of diabetic
patients compared with nondiabetic (NIDDM, P ¼ .01; IDDM, P ¼ .02).
Reduction in limb salvage rates was associated with presence of tissue loss
at presentation, end-stage renal disease, and progression of distal disease
on follow-up.
Conclusions. Endoluminal therapy for SFA occlusive disease yields lower as-
sisted patency rates and higher restenosis rates for those patients presenting
with claudication who have more advanced diabetes (ie, IDDM). Among
those patients presenting with CLI, particularly those with tissue loss, limb
salvage rates are lowered for the diabetic groups (NIDDM and IDDM)
despite equivalent patency and restenosis rates.
Stenting of the venous outflow in chronic venous disease: Long-term
stent-related outcome, clinical, and hemodynamic result
P. Negle´n, K.C. Hollis, J. Olivier and S. Raju
Background. Stenting of chronic nonmalignant obstruction in the venous out-
flow tract started in earnest in 1997. Data sets are now available to perform
long-term analysis of stent-related outcome and clinical and hemodynamic
results of this intervention.
Materials. From 1997 to 2005, 982 chronic nonmalignant obstructive lesions
of the femoroiliocaval vein were stented under intravascular ultrasound
guidance. Median patient age was 54 years (range, 14 to 90 years), the fe-
male/male was 2.6:1, and left/right limb symptoms, 2.4:1. Clinical score of
CEAP was 2 in 7%, 3 in 47%, 4 in 24%, 5 in 5%, and 6 in 17%; primary/sec-
ondary etiology was 518:464. Stent-related outcome (morbidity, thrombotic
events, patency, in-stent recurrent stenosis), clinical outcome, quality of life
(QOL) as assessed by the Chronic Venous Insufficiency Quality of LifeQuestionnaire (CIVIQ), and hemodynamics were evaluated before and after
intervention.
Result. Monitoring for 94% of patients lasted a mean 22 months (range, 1 to
107 months). Stenting was performed with no mortality (<30 days) and low
morbidity. Thrombotic events were rare (1.5%) during the postoperative pe-
riod (<30 days) and during later follow-up (3%). At 72 months, primary, as-
sisted-primary, and secondary cumulative patency rates were 79%, 100%, and
100% in nonthrombotic disease and 57%, 80%, and 86% in thrombotic disease,
respectively. Cumulative rate of severe in-stent restenosis (>50%) occurred in
5% of limbs at 72 months (10% in thrombotic limbs, 1% in nonthrombotic
limbs). The main risk factors associated with stent occlusion were the pres-
ence and severity of thrombotic disease; thrombophilia by itself was not
a risk factor. The median pain score and degree of swelling decreased signif-
icantly poststent. Severe leg pain (visual analogue scale >5) and leg swelling
(grade 3) decreased from 54% and 44% prestent to 11% and 18% poststent,
respectively. At 6 years, cumulative rates of complete relief of pain and swell-
ing were 62% and 32%, respectively, and ulcer healing was 58%. The mean
CIVIQ scores of QOL improved significantly in all categories. Mean hand-
foot pressure differential decreased and mean ambulatory venous pressure
improved in stented limbs with no concomitant reflux. The hemodynamic re-
sponse was modified, depending on the presence of deep and superficial re-
flux in subsets of patients with adjunct saphenous procedures. No increase in
venous reflux was observed.
Conclusions. Venous stenting can be performed with low morbidity and mor-
tality, long-term high patency rate, and a low rate of in-stent restenosis. It re-
sulted in major symptom relief in patients with chronic venous disease,
which was not consistently reflected in any substantial hemodynamic im-
provement by conventional measurements. The beneficial clinical outcome
occurred regardless of presence of remaining reflux, adjunct saphenous pro-
cedures, or etiology of obstruction.Eur J Vasc Endovasc Surg Vol 34, November 2007
